The Izvestia News Center's press center talks about the first Russian drugs from donated blood plasma. Broadcast

A press conference dedicated to the development and implementation of Russian drugs based on donated blood plasma is being held at the Izvestia International Medical Center.

How was the hemophilia drug developed and how does it differ from other analogues? How is donor plasma used in the manufacture of medicines? In what cases are plasma medications used, including emergency and elective surgeries? Why are these drugs considered strategically important for the treatment of severe infections, blood loss, and emergency medicine?

Participants:

— Tatiana Gaponova, Chief Freelance Transfusiologist at the Ministry of Health of the Russian Federation, First Deputy General Director of the Federal State Budgetary Institution "NMITS of Hematology" of the Ministry of Health of the Russian Federation, MD.;

— Evgeny Golubev, Head of the Experimental Production Department of Deep Plasma Processing at the National Research Medical Center of Hematology of the Ministry of Health of the Russian Federation.